- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04999982
Pilot Testing PREschooler Care, Community Resources, Advocacy, Referral, Education (PRE-CARE) (PRE-CARE)
Pilot Testing PRE-CARE to Address Unmet Social Needs for Preschoolers With Inattention and/or Hyperactivity
The goal of this proposed study is to pilot test a novel treatment model (PRE-CARE) addressing unmet social needs for families of preschool-age children with Attention Deficit/Hyperactivity Disorder (ADHD) symptoms. The investigators will conduct an adaptive, pilot randomized controlled trial (RCT) of the intervention with parents of 60 low-income children age 3-5 (36-71 months) with ADHD symptoms in order to: optimize intervention delivery; field test study logistics (e.g., recruitment, enrollment, randomization, retention); explore putative intervention mechanisms; and obtain estimates of study parameters to plan an appropriately powered RCT of the intervention.
The PRE-CARE intervention is adapted from Well Child Care, Evaluation, Community, Resources, Advocacy, Referral, Education (WE CARE), a screening and referral intervention that has been shown to be feasible and effective in addressing the family psychosocial stressors of low-income families seen in pediatric medical homes. Given the negative impact that socioeconomic stressors can have on the health and development of young children with ADHD symptoms, tailored interventions such as PRE-CARE may serve as a vital early intervention strategy to promote long-term well-being.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Ann & Robert H. Lurie Children's Hospital of Chicago
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Legal guardian and primary caregiver of a child aged 36-71 months
- Legal guardian or primary caregiver is age 16 years or older
- Child receives pediatric care at Boston Medical Center or at one of the participating affiliated clinics
- Able to understand informed consent procedures in English or Spanish
Participant has a child aged 36-71 months with an ADHD diagnosis, OR one elevated total or subscale score at the 80th percentile on the ADHD-Rating Scale-IV Preschool Version. 80th percentile cut-offs on the ADHD-Rating Scale-IV Preschool Version are as follows:
- For male children, a total score ≥ 25 OR subscale score (inattention and/or hyperactivity) ≥ 12
- For female children, a total score ≥ 13 OR subscale score (inattention and/or hyperactivity) ≥ 6 for female children
Exclusion Criteria:
- There are no specific exclusion criteria for this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group- PRE-CARE
Participants will receive the 1:1 PRE-CARE social needs navigation intervention with specific content and delivery strategy which was developed based on 1) quantitative analyses of the association between unmet social needs and ADHD symptoms in a large-scale nationally representative sample of children age 3-5, and 2) in-depth qualitative interviews with parents/guardians of preschoolers with inattention and/or hyperactivity symptoms to identify mechanisms by which unmet social needs exacerbate ADHD symptoms and functioning.
|
Parent-report screening for remediable, unmet social needs.
Provision of packet of resource sheets ("Family Resource Booklet") detailing local community-based resources to address these needs, with needs that respond to family's requests highlighted.
Navigation to resources, care coordination, and parent support provided by a trained bachelors-level interventionist.
|
|
Active Comparator: Control group- Care as Usual
Families randomly assigned to the control condition will continue to receive care as usual, which includes screening for social needs annually at well-child visits as recommended by the American Academy of Pediatrics (AAP), followed by provision of information as needed by the family.
Families will also be offered the opportunity to make research assessments available to their primary care physician for best continuity of care.
|
Screening for social needs annually at well-child visits as recommended by the AAP followed by provision of information as needed by the family.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ADHD Symptoms
Time Frame: Baseline, 3 months, 6 months, and 12 months
|
ADHD-Rating Scale (RS)-IV Preschool Version is a parent-report survey that measures presence and severity of ADHD symptoms for preschoolers.
In our study, we used this measure to assess overall ADHD symptom burden.
The 18-item validated scale asks parents about the 18 diagnostic criteria for ADHD and how often their child exhibits each symptom.
The scale can be used as an overall score (total symptoms) or by subscales (9-item inattention subscale and 9-item hyperactivity subscale).
Responses are reported by parents for each item along a 4-point Likert scale from 0 to 3, where 0=rarely or never and 3=very often.
For our purposes, we computer the total score for a measure of total ADHD symptom severity, and did not use the subscales.
Total scores range from 0 to 54, where lower is less ADHD symptoms/lower symptom severity, and higher scores represent higher symptom severity.
|
Baseline, 3 months, 6 months, and 12 months
|
|
Total Resources Enrolled (Parent Report)
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Resource access was measured based on a parent report checklist of resources enrolled.
The checklist was based on the Child HealthWatch Survey and modeled after data collected for the clinical trial testing the original social determinants intervention on which this intervention is based.
The checklist included 18 resources that families could be enrolled in (for example - healthcare services, mental health care, special education, food benefits, housing assistance, etc), and asked parents to indicate which resources they were enrolled in.
The end result is a count between 0 and 18 representing how many resources their family was enrolled in.
Higher numbers indicate higher number of resources enrolled, whereas lower numbers indicate lower number of resources enrolled.
|
Baseline, 3 months, 6 months, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Global Perceived Stress
Time Frame: baseline, 3 months, 6 months, 12 months
|
The Perceived Stress Scale (PSS) will be used to measure perceptions of levels of stress within the past month using 10 items on a 4 point Likert scale indicating 0 = Never, 1 = Almost Never, 2 = Sometimes, 3 = Fairly Often, and 4 = Very Often.
Higher scores [range 0 to 40] are correlated with more perceived stress.
|
baseline, 3 months, 6 months, 12 months
|
|
PRE-CARE Feasibility and Acceptability Questionnaire
Time Frame: 3 months
|
The PRE-CARE Feasibility and Acceptability Questionnaire will be used to measure intervention satisfaction using 14 items on a 4 point Likert scale.
Items will ask about satisfaction of information and resources provided, length of intervention, perceived helpfulness of intervention, and whether or not they would recommend the program to a parent of a similarly aged child.
Higher scores are correlate with greater satisfaction.
|
3 months
|
|
Child Psychiatric Symptoms
Time Frame: Baseline, 6 months, 12 months
|
The Child Behavior Checklist 1.5-5 (CBCL 1.5/5) is a standardized tool used to assess child psychiatric symptoms for children 1.5-5 years old.
The questionnaire obtains caregivers' ratings of 99 problem items along a Likert scale.
Parents/caregivers rate each item 0=not true, 1=somewhat or sometimes true, 2=very true or often true of the child (based on the preceding 6 months).
Higher scores are correlated with more psychiatric symptoms.
Items can be grouped into syndrome scales or the total score can be used to represent overall psychiatric symptom severity.
Here we use the total score to represent total psychiatric symptoms.
Scores are reported as t-scores, where 50 indicates the population mean with a standard deviation of 10.
Higher scores indicate more symptoms.
On this scale, scores between 65 and 69 are considered borderline elevated, and scores of 70 or more are considered clinically significant.
|
Baseline, 6 months, 12 months
|
|
Parental Depression
Time Frame: baseline, 3 months, 6 months, 12 months
|
Patient Health Questionnaire (PHQ)-9 will be used to measure frequency and severity of parental symptoms of depression within the past two weeks.
The measure is the major depressive disorder (MDD) module of the full PHQ, and scores each of the 9 Diagnostic and Statistical Manual criteria of MDD as "0" (not at all) to "3" (nearly every day), providing a 0-27 severity score.
Higher scores are correlated with more parental depression.
|
baseline, 3 months, 6 months, 12 months
|
|
Parental Attention-deficit/Hyperactivity Disorder (ADHD)
Time Frame: baseline, 3 months, 6 months, 12 months
|
Adult ADHD Self-Report Scale (ASRS-v1.1)
Symptom Checklist will be used to measure parent ADHD symptoms.
The measure consists of 18 items matching Diagnostic and Statistical Manual IV criteria for adult ADHD.
Items are scored on a 5-point Likert scale, (Never, Rarely, Sometimes, Often, Very Often).
The questionnaire is scored based on number of symptoms, leadng to a score between 0 and 18 for the questionnaire.
Items 1, 2, 3, 9, 12, 16, 18 are each counted as a symptom (1 point each) if the participant answers Sometimes, Often, or Very Often.
Items 4, 5, 6, 7, 8, 10, 11, 13, 14, 15, 17 are each counted as a symptom (1 point each) if the participant answers Often or Very Often.
Higher scores indicate higher symptom burden.
|
baseline, 3 months, 6 months, 12 months
|
|
Parenting Stress
Time Frame: baseline, 3 months, 6 months, 12 months
|
The Parenting Stress Inventory, Short Form (PSI-4-SF) will be used to measure specific levels of stress in relation to taking care of their child and the parent-child system.
The scale includes 36 items, each of which uses a 4-point Likert scale from Strongly Disagree to Strongly Agree.
The scale includes subscales and a Total score representing total stress on parents, reported here.
Possible scores range from 36 to 180.
Higher scores are correlated with more parental stress.
|
baseline, 3 months, 6 months, 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Andrea Spencer, MD, Ann & Robert H Lurie Children's Hospital of Chicago
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Neurodevelopmental Disorders
- Attention Deficit and Disruptive Behavior Disorders
- Attention Deficit Disorder with Hyperactivity
- Health Care Quality, Access, and Evaluation
- Investigative Techniques
- Epidemiologic Methods
- Diagnostic Techniques and Procedures
- Diagnosis
- Data Collection
- Health Care Evaluation Mechanisms
- Quality of Health Care
- Public Health
- Environment and Public Health
- Health Services
- Health Care Facilities Workforce and Services
- Preventive Health Services
- Diagnostic Services
- Health Surveys
- Surveys and Questionnaires
- Public Health Practice
- Mass Screening
Other Study ID Numbers
- IRB 2023-6209
- 5K23MH118478-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit/Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
-
Rutgers, The State University of New JerseyNational Institute of Mental Health (NIMH); Louisiana State University Health...Recruiting
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
Clinical Trials on Screening
-
Vastra Gotaland RegionRecruiting
-
Children's Hospitals and Clinics of MinnesotaCompletedFirearm Injury | Firearm Safety | Firearm OwnershipUnited States
-
University of British ColumbiaUniversity of SydneyRecruitingCardiovascular Diseases | End Stage Renal Disease | Kidney Transplantation | Dialysis Related ComplicationCanada, United States, United Kingdom, Germany
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
University of FloridaPatient-Centered Outcomes Research InstituteEnrolling by invitation
-
Peking University People's HospitalSun Yat-sen University; Fudan University; Sun Yat-Sen Memorial Hospital of Sun... and other collaboratorsCompletedBreast Cancer | Bone MetastasesChina
-
National Institute of Allergy and Infectious Diseases...Ohio Department of Health, City of Cincinnati Board of HealthCompleted
-
University of La LagunaCompletedHepatitis C Virus InfectionSpain
-
University of PittsburghNational Institute of Mental Health (NIMH); Kaiser Foundation Research InstituteCompleted
-
University of La LagunaRecruiting